title: Fingolimod-induced asthma deterioration in a patient with relapsing-remitting multiple sclerosis.
authors.affiliation: VU University Medical Center, Amsterdam, The Netherlands j.vanrossum@vumc.nl.
authors.forename: J A
authors.initials: JA
authors.lastname: van Rossum
authors.affiliation: VU University Medical Center, Amsterdam, The Netherlands.
authors.forename: E E
authors.initials: EE
authors.lastname: Looysen
authors.affiliation: VU University Medical Center, Amsterdam, The Netherlands.
authors.forename: J M A
authors.initials: JM
authors.lastname: Daniels
authors.affiliation: MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
authors.forename: J
authors.initials: J
authors.lastname: Killestein
mesh_terms: D000328:Adult; D001249:Asthma / Q000139:chemically induced*; D005260:Female; D000068876:Fingolimod Hydrochloride; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D011409:Propylene Glycols / Q000009:adverse effects*; D013110:Sphingosine / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine